Background It has been suggested that inhaled corticosteroids may provide greater protection against constrictor stimuli that act indirectly such as exercise than those that act directly such as histamine. Methods The effects of six weeks treatment with inhaled budesonide (800 ug twice daily) on bronchial reactivity to histamine, exercise, and eucapnic voluntary hyperventilation of dry air were compared in a double blind, placebo controlled, non-crossover study in 40 subjects with asthma. Change in bronchial reactivity to histamine and eucapnic hyperventilation over the six weeks was measured as change in the provocative dose of histamine or dry air causing a 20% fall in FEV, (PD20 histamine and PV20 eucapnic hyperventilation (EVH) of dry air); this was not possible for exercise because of the development of refractoriness. To enable the change in response to all three stimuli to be compared, the response (percent fall in FEV,) to a fixed dose was measured for all three challenge tests. Results After budesonide there was an increase in PD20 histamine from 0-48 to 2-81 pmol and in PV20 EVH from 364 to 639 litres, and a significant correlation between the changes in PD20 histamine and PV20 EVH (r = 0-63). The median percentage fall in FEV, in response to eucapnic hyperventilation, exercise, and histamine was similar before budesonide (25-5%, 26-6%, and 24-5%); the reduction in the percentage fall in FEV, with budesonide was also similar for the three challenges (18-9%, 17-5%, and 16-6%), and all differed significantly from the changes following placebo. There was a significant correlation between change in percentage fall in FEV, after budesonide with the three stimuli (histamine v exercise: r = 0-48; histamine v eucapnic hyperventilation: r = 0-46; exercise v eucapnic hyperventilation: r = 0-63). Conclusion The similar magnitude of change in bronchial reactivity to all three stimuli after budesonide and the within subject correlation obtained between these changes suggest that corticosteroids act by a common mechanism to protect against eucapnic hyperventilation, exercise, and histamine.
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Patients with asthma show increased airway reactivity to a wide range of stimuli, some of which appear to act directly on airway smooth muscle and some indirectly through mast cell mediator release or sensory nerve stimulation. Drugs such as beta2 agonists reduce bronchial reactivity irrespective of the stimulus, whereas others, such as sodium cromoglycate and inhaled frusemide, reduce the airway response to challenges that act indirectly, such as exercise,' 2metabisulphite,3'4 and cold air hyperventilation,5 with little or no effect on directly acting stimuli such as histamine and methacholine.67
Corticosteroids when given regularly have been shown to inhibit the response to most bronchoconstrictor stimuli,"'9 but whether they give similar protection against different forms of challenges is not clear. It has been suggested that they may have a greater effect on exercise induced bronchoconstriction than that induced by histamine,'3 15 and this could explain why inhaled corticosteroids are more effective in clinical practice than might be expected from their relatively modest effect on histamine reactivity. The greatest change in the provocative dose of histamine causing a 20% fall in FEV, (PD20) with inhaled corticosteroids in placebo controlled studies has been only 1-2 doubling doses,"'0 though recent uncontrolled studies have shown larger changes'6"9 and a change of two doubling doses of methacholine was seen in a recent placebo controlled study. '8 We have therefore compared the effect of six weeks' treatment with budesonide 800 jug twice daily on the airway response to histamine, exercise, and eucapnic voluntary hyperventilation in 40 patients with asthma. A detailed analysis of our findings on the time course of change in airway reactivity to histamine before and after the end of treatment has been published.20
Certain problems had to be addressed in assessing the relative effect of corticosteroids on histamine and exercise induced bronchoconstriction as different methods are normally used to assess the response to the two stimuli. The effect of the drug on the response to histamine is usually measured as the change in PD20, a measure of the shift in the dose- Measurement of bronchial reactivity to eucapnic hyperventilation was carried out according to the method described by Phillips et al. 26 The subjects, seated and with a noseclip fitted, inhaled dry air containing 5% carbon dioxide at room temperature from a 6 litre target reservoir bag through a Collins triple J valve. The bag was filled continuously from a cylinder containing the dry gas mixture via a rotameter, which was regulated to achieve the desired minute ventilation. After baseline measurement of FEV1 the subject breathed the dry air mixture at 20 1/min for four minutes. A six minute exercise challenge was carried out with continuous electrocardiographic monitoring on a treadmill at room temperature (maintained at 18-20°C), with the subject wearing a noseclip and breathing dry air through a mouthpiece from a cylinder via a Collins triple J valve and a 100 litre Douglas bag reservoir. A nomogram27 was used to determine the level of exercise (running speed and incline) required to attain a heart rate of 90% predicted maximum for each patient. FEV, was measured before exercise and three, five, 10, 15, and 20 minutes after exercise and the maximum fall from the pre-exercise baseline determined. Two practice exercise tests were carried out on different days to determine the six minute workload for each patient that would cause a fall in FEV1 of around 20%. The workload was then kept constant for subsequent tests.
STUDY DESIGN
The study was a double blind, non-crossover comparison in which subjects were randomly allocated to receive either inhaled budesonide 800 tg twice daily or placebo for six weeks.
Bronchial reactivity to eucapnic hyperventilation, exercise, and histamine was measured (in that order) on three consecutive days at the same time of day (0830) (fig 1) . The increase in PD20 was significantly larger with budesonide than with placebo, by 2A4 doubling doses (95% CI 0-5 to 3-6, p < 0-01). Median PV20 EVH increased with budesonide treatment from 364 to 639 litres and with placebo from 347 to 419 litres. The difference between the increases for the two groups (0-6 doubling doses) was not significant (95% CI -0-05 to 1-05, p = 0-07).
The median exercise % fall in FEV, decreased after budesonide treatment from 23-5% to 6-7% and after placebo from 25-6% to 22 1%, the difference of 13 3% (95% CI 3-5 to 27.5) being significant (p < 0 01).
COMPARISON OF CHANGE IN BRONCHIAL REAC-TIVITY TO HISTAMINE, EUCAPNIC HYPERVENTI-LATION, AND EXERCISE WITH BUDESONIDE TREAT-MENT
Changes in PD20 histamine and PV20 EVH correlated closely (fig 2: r = 0 63, p < 00 1). As the change in PV20 EVH would have been underestimated in seven of the 18 subjects because censored values were used, the relation between change in PV20 EVH and PD20 histamine was examined in the 11 comparison between stimuli only if the doseresponse relationships for the different stimuli are similar, so that a unit shift in the doseresponse curve for one stimulus (one doubling dose, for example) is equivalent to the same unit shift for another stimulus. Another problem with this method is that with some stimuli it may be difficult to obtain a doseresponse curve; this is the case with exercise, for example, because of the problem of refractoriness with repeated challenges.2324 Neither method is entirely satisfactory but using the same method to compare the responses to treatment is preferable to using different methods for different stimuli. We therefore compared the change in reactivity to histamine and eucapnic hyperventilation after inhalation of budesonide in terms of the shift in the doseresponse curve, and we compared the change in reactivity to all three stimuli using the fixed dose-response method.
Budesonide provided very effective protection against exercise induced asthma in our study, the percentage fall in FEV, after exercise being reduced from 23-5% to 6 There is no information on the effect of corticosteroids on bronchoconstriction induced by eucapnic hyperventilation. In our study budesonide caused a reduction in the percentage fall in FEV1 with eucapnic hyperventilation (18-9%) similar to that seen with exercise (17 1%) and histamine (16-6%). In some patients, particularly after histamine inhalation and exercise, the response was small after budesonide, suggesting that it may not be on the linear part of the budesonide doseresponse curve. This may have caused the percentage fall to be underestimated in some patients. Although the percentage fall in FEV1 was similar for histamine and eucapnic hyperventilation the change in PD20 and PV20 after budesonide differed, being 2A4 doubling doses for histamine but only 06 doubling doses for PV20 EVH. This difference between eucapnic hyperventilation and histamine is similar to that seen with beta2 agonists, where the shift in the dose-response curves for cold air is much less than that seen with histamine after the same dose of beta2 agonist.303' These data highlight the fact that the relation between change in percentage fall in FEV, and the shift of the dose-response curve (,IPD20, zjPV20) is different for histamine and eucapnic hyperventilation and show that a unit shift in the dose-response curve for one stimulus is not equivalent to a unit shift in the dose-response curve for another stimulus. This may be the reason why pretreatment PD20 histamine in the study group ranged over 6 doubling doses whereas the range of PV20 EVH in the same subjects was much smaller, only 2-5 doubling doses. Comparing the changes obtained with the three stimuli after budesonide treatment as change in the percentage fall in FEV, is, we believe, more valid in these circumstances than measuring the shift in the dose-response curve. When expressed in this way our results suggest that budesonide has a similar effect on bronchial reactivity to all three stimuli.
The mechanisms underlying the bronchoconstrictor response to eucapnic hyperventilation, exercise, and histamine appear to differ. Exercise and dry air hyperventilation are thought to act by cooling or drying ( 
